The SAGA around DNA’s burning company for the 23andma is taking another unexpected opportunity. Last month, the Biotech Firm Regeneron bought company goods – including its 15 million database for nearly 15 million users – $ 256 million for a consumption. However, a large bid from Anne Wojcicki, the Orthemi founder and former CEO, has attended a second trench.
In the Court ear in St.. Louis, Mother. Yesterday (June 4), 23andme’s lawyer revealed that a monthly monthly monthly martial proposal amounted to $ 305 million. Wojcicki, who has left 23andome in March and disobeyed the first old age, included forces with his / her research center for Sofit TTAM.
After the Revelation, representatives from 23andme, etam, and Reveneron reached the resetting agreement. The second part, scheduled to leave this month, will begin with a new TTAM – about $ 50 million than the winning bid of Regeneron.
23andme shares increases more than 24 percent today after news.
What happened to 23andme?
The travel noticed the conversation area in 23andme’s reduction. It was founded in 2006 by Wojcicki, the company found the filling of theater based on sale and traveled in the community in 2021. At the end of this year, the following order is full of $ 6 billion.
However, its financial situation deteriorated quickly. 23andome fought to produce unchanging revenues above their DNAs, customers were purchased once. In 2023, the company faced the violation of important data that presented information from approximately 7 million users, which resulted in the official action of the action. Earlier this year, the 11th chapter was filled.
AMD 23andma’s working, anxiety grew on the future of its largest DNA data, and world lawyers is urging users to remove their genetic data on the platform. When Reveneron announced their company’s assets last month, he promised adherence to privacy policies and procedures for the genetic database – TTAM Commitation and respect should have won the coming area.
Regeneron, who establishes various diseases, said that the planned to use data to speed up medical research. The company agreed to approve the Ombudsman set in court and other stakeholders to review the actual privacy practices.
Other Sales in Cards
The coming 23andma, TTAM will kick the process with its $ 305 million. Regenerron will be asked to set a higher bid, starting $ 315 million, after which TTAM will have two hours to respond to the final proposal before the final bid is going to Reegeneron. The lawyers both of both sides have agreed that the loss bid will accept $ 10 million. “
TTAM’s new BID from $ 146 million is provided by last month old, and exceeds the most than $ 40 million Bid Wijcicki bid before 23andme is inserted into extinction in March. The US Stafftupcy Carian Walsh described the principles discussed in a new auction as “the best” of equality in the same time yesterday to hear.
